DIABNEXT develops mobile solutions, cloud technology, and connected devices to create Artificial Intelligence that optimizes Diabetes and Pre-Diabetes Management.
Company (Alive / Active)
3 rue Léon Gatin
|Investor||Investor Type||Location||Participating Rounds|
|Salem, Massachusetts, United States||Alive / Active||Glymetrix aims to provide engagement strategies to motivate better diabetes management through the use of rewards and incentives. Glymetrix uses a game based interface to engage patients with a data model at the core of the system.||Login to see details|
|Baltimore, Maryland, United States||Alive / Active||WellDoc, a healthcare behavioral science and technology company that develops solutions aimed at engaging patients and enhancing health outcomes, is focused on simplifying the way chronic diseases are managed through a collaborative approach that breaks down the barriers of engagement and adherence by providing patients and healthcare providers with real-time information. WellDoc has developed a technology-based solution designed to help people with chronic diseases better manage conditions. The...Show all||Login to see details|
|Title||Application Date||Patent Date||Status
(Patent / Application)